Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria
Open Access
- 10 March 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Health Policy and Planning
- Vol. 24 (3) , 189-196
Abstract
The anti-retroviral (ARV) treatment programme in Nigeria is delivered through selected teaching and mission hospitals at a free/subsidized rate. The government aims to scale up ARV treatment in the country. However, non-adherence to ARV medication can lead to viral resistance, treatment failure, toxicities and waste of financial resources. This study examined the factors responsible for non-adherence to free/subsidized ARV treatment in south-east Nigeria. The study was cross-sectional and descriptive. Information was collected from 174 patients selected by simple random sampling from the register of all patients who had been on anti-retroviral therapy (ART) for at least 12 months at the beginning of the study period. Patients were identified during their clinic visits. Information on their socio-demographic profile, ARV treatment and determinants of non-adherence to ARV treatment was obtained from those who gave consent, using pre-tested interviewer-administered questionnaires. All patients clearly understood the need to take ARV drugs throughout their lives, and what the costs entailed. They understood the need for periodic testing, the probability that complications would develop, cost of transportation to treatment site and the daily treatment regimen. Seventy-five per cent of respondents were not adhering fully to their drug regimen; the mean number of days that respondents had been off drugs was 3.57 days the preceding month. Reasons for non-adherence included: physical discomfort (side effects); non-availability of drugs at treatment site; forgetting to carry drugs during the day; fear of social rejection; treatment being a reminder of HIV status; and selling of own drugs to those unable to enrol in the projects. Being female, under 35 years, single, and having higher educational status were significantly associated with non-adherence. It is important that policy makers and programme managers address the factors responsible for non-adherence when scaling up subsidized ARV treatment in Nigeria and other parts of sub-Saharan Africa.Keywords
This publication has 25 references indexed in Scilit:
- Defaulters from antiretroviral treatment in Jimma University Specialized Hospital, Southwest EthiopiaTropical Medicine & International Health, 2008
- The Role of Psychosocial and Family Factors in Adherence to Antiretroviral Treatment in Human Immunodeficiency Virus-Infected ChildrenThe Pediatric Infectious Disease Journal, 2004
- What policymakers should know about drug resistance and adherence in the context of scaling-up treatment of HIV infectionAIDS, 2004
- Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South AfricaAIDS, 2004
- Adherence to Antiretroviral Therapy Among Patients With HIV: A Critical Link Between Behavioral and Biomedical SciencesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- A prospective study of predictors of adherence to combination antiretroviral medicationJournal of General Internal Medicine, 2002
- Preventing antiretroviral anarchy in sub-Saharan AfricaThe Lancet, 2001
- Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence InstrumentsAIDS Care, 2000
- Management of the Adverse Effects of Antiretroviral Therapy and Medication AdherenceClinical Infectious Diseases, 2000
- Adherence to Antiretroviral and Pneumocystis Prophylaxis in HIV DiseaseJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998